Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE)

The Journal of Clinical Investigation
C B CarpenterK F Austen

Abstract

Highly purified and radioiodinated human C4 and (or) C3 were administered to patients with renal allografts in rejection, with hereditary angioedema (HAE), with chronic glomerulonephritis, and to control subjects. The latter group included normal individuals, anephric patients before transplantation, and stable renal allograft recipients. The catabolic rates of these complement proteins were determined by analysis of the disappearance of plasma protein-bound radioactivity (k(m)), and by direct measurement of urinary excretion of radioactivity (k(u)). The correlation coefficient between these two methods was 0.96. The mean +/-2 SD for catabolic rates in the control subjects was 0.9-2.7% plasma pool/hr for C4 and 0.9-2.0% plasma pool/hr for C3. Patients experiencing renal allograft rejection had unstable levels of C4 and C3, and exhibited moderate hypercatabolism of both proteins. One patient with chronic glomerulonephritis had hypercatabolism of C4 and C3 in the presence of stable normal serum levels. In patients with HAE who had extremely low levels of C4, catabolic rates for C4 were markedly elevated (3.7, 5.8, 7.0 and 8.8%/hr). Analysis of plasma curves in HAE revealed a three component disappearance curve instead of the two ...Continue Reading

References

Jan 1, 1966·International Archives of Allergy and Applied Immunology·P J McConahey, F J Dixon
Dec 1, 1967·The American Journal of Medicine·C B CarpenterG J Dammin
Nov 1, 1969·The Journal of Clinical Investigation·L D PetzJ Müller-Eberhard
Dec 1, 1967·The Journal of Clinical Investigation·C A Alper, F S Rosen
Aug 1, 1953·The Journal of Clinical Investigation·S A BERSONJ POST
Jul 1, 1956·The International Journal of Applied Radiation and Isotopes·R M CAMPBELLA S MCFARLANE
Mar 1, 1961·The Journal of Clinical Investigation·C M MATTHEWS
Jun 1, 1962·The Journal of Clinical Investigation·W L BEEKENR S STEMLER
Sep 1, 1963·The Journal of Experimental Medicine·H J MUELLER-EBERHARD, C E BIRO
Nov 1, 1964·The Journal of Clinical Investigation·V H DONALDSON, F S ROSEN
May 1, 1965·The Journal of Experimental Medicine·H J MUELLER-EBERHARD, I H LEPOW
Aug 1, 1965·The Journal of Experimental Medicine·U R NILSSON, H J MUELLER-EBERHARD

❮ Previous
Next ❯

Citations

Jan 1, 1972·Arthritis and Rheumatism·A WeinsteinR Bluestone
Mar 1, 1974·Arthritis and Rheumatism·M M De Bracco, J A Manni
Jul 15, 1975·Klinische Wochenschrift·L Levi
Jan 1, 1979·Journal of Immunological Methods·L BrinchI Aakesson
Sep 26, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Kusumam JosephAllen P Kaplan
Jun 12, 1969·The New England Journal of Medicine·F S Rosen, K F Austen
Aug 31, 1972·The New England Journal of Medicine·A L ShefferF S Rosen
Sep 14, 1972·The New England Journal of Medicine·S RuddyK F Austen
Jun 6, 1974·The New England Journal of Medicine·S Ruddy, H R Colten
May 5, 1983·The New England Journal of Medicine·M SchapiraR W Colman
Feb 28, 1985·The New England Journal of Medicine·R S GehaF S Rosen
Jul 1, 1997·AIDS Research and Human Retroviruses·M GerencerF Dorner
Feb 1, 1975·British Journal of Haematology·L E SpitlerH H Fudenberg
Jan 1, 1978·Vox Sanguinis·H KitamuraN K Day
Oct 1, 1975·Journal of Oral Pathology·J E Volanakis
Dec 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D M RickerJ D Clough
Sep 1, 1979·Clinical Allergy·C SeignaletF B Michel
Nov 7, 2006·Immunology and Allergy Clinics of North America·Alvin E Davis
Mar 1, 1977·The Journal of Allergy and Clinical Immunology·G W Brasher
Jun 1, 1975·The Journal of Allergy and Clinical Immunology·C J JaffeM M Frank
Feb 11, 2015·Analytical Biochemistry·Elizabeth C SchrammPaul K Olson
Feb 11, 2015·Autoimmunity Reviews·Irène Gallais SérézalOlivier Fain
Dec 30, 2014·Pediatric Allergy, Immunology, and Pulmonology·Sonia CacciaMarco Cicardi
Mar 1, 1974·The American Journal of Medicine·P F KohlerC J Smyth
May 7, 1971·Nature·I M Murray-LyonH G Clarke
Sep 1, 1980·Scandinavian Journal of Clinical and Laboratory Investigation·L Brinch, I Aakesson
Dec 24, 2019·Proteomics. Clinical Applications·Lina Zhang, Qibin Zhang
Jul 1, 1980·Scottish Medical Journal·Z Ballogh, K Whaley
Jan 1, 1972·Humangenetik·F Kueppers, K H Schulz
May 15, 2019·International Journal of Molecular Sciences·Alena SobolevaAndrej Frolov
Dec 13, 2017·International Journal of Molecular Sciences·Alena SobolevaAndrej Frolov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.